5361 - 5370 of 8606 Results
Title
Year
-
OPENTitle: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06534-8Best OA location URL: https://www.nature.com/articles/s41419-024-06534-8.pdfCitation Count: 5
-
OPENTitle: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 206Issue #:Start Page: 106820End Page: 106820Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820Best OA location URL: https://doi.org/10.1016/j.nbd.2025.106820Citation Count: 0
- Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonism2013RESTRICTEDTitle: Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.02.016Citation Count: 0
-
OPENTitle: Spring is in the air: seasonal profiles indicate vernal change of miRNA activityJournal Name: RNA BiologyPublisher: Informa UK LimitedVol: 16Issue #: 8Start Page: 1034End Page: 1043Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15476286.2019.1612217Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15476286.2019.1612217?needAccess=trueCitation Count: 14
- IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synuclein2014OPENTitle: IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://doi.org/10.1002/prp2.65Citation Count: 43
- Leveraging sex-genetic interactions to understand brain disorders: recent advances and current gaps2024OPENTitle: Leveraging sex-genetic interactions to understand brain disorders: recent advances and current gapsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae192Best OA location URL: https://doi.org/10.1093/braincomms/fcae192Citation Count: 0
-
RESTRICTEDTitle: Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1601End Page: 1608Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27362Citation Count: 241
- Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs2019OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 18
-
OPENTitle: Visual Hallucinations in Eye Disease and Lewy Body DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 24Issue #: 5Start Page: 350End Page: 358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2015.10.007Best OA location URL: http://www.ajgponline.org/article/S1064748115002687/pdfCitation Count: 28
- Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+T cells, and M1 macrophages2020OPENTitle: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+T cells, and M1 macrophagesJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 8Issue #: 2Start Page: e001617End Page: e001617Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jitc-2020-001617Best OA location URL: https://jitc.bmj.com/content/jitc/8/2/e001617.full.pdfCitation Count: 42